The Influence of Depression and Anxiety on Neurological Disability in Multiple Sclerosis Patients

Table 3

Psychological test score details according to MS type and treatment.

	BDI	ATQ	EMAS-S
MS type, mean
CIS	5.87	27.37	25.62
RRMS	10.34	27.35	35.21
SPMS	16.5	29.2	43.4
Actual DMT, mean
IFN-beta-1a i.m.	10.20	26.33	34.63
IFN-beta-1b	11.75	29.50	41.75
Glatiramer acetate	12.62	29.89	35.16
Mitoxantrone	13.50	33.50	50.00
IFN-beta-1a s.c.	6.90	27.29	30.95
Natalizumab	8.22	20.33	34.56
No current medication	10.72	27.44	38.67
Total (), mean [SD] (range)	10.52 [9.67] (0-54)	27.48 [11.23] (15-59)	35.25 [16.4] (20-87)